4Banjamin E J,Wolf P A,D'Agostino R B,et al. Impact of atrial fibrillation on the risk of death[J]. Circulation, 1998,98 (10) : 946-952.
5Wang T J, Larson M G, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study [J]. Circulation, 2003,107 (23) : 2920-2925.
6Fioranelli M, Piccoli M, Mileto G M, et al. Modifications in cardiovascular functional parameters with aging [J]. Minerva Cardioangiol, 2001,49 (3) : 169 - 178.
7Fung J W,Chan S K,Yeung L Y,et,al. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials[J]. Eur J Heart Fail,2002,4(4):489-494.
8Tsang T S,Barnes M E,Gersh B J,et al. Risks for atrial fibrillation and congestive heart failure in patients≥f65 years of age with abnormal left ventricular diastolic relaxation [J]. Am J Cardiol, 2004,93 (1) : 54-58.
9Sam C,Massaro J M,D'Agostino R B Sr,et al. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study) [J]. Am J Cardiol, 2004,94 (7) : 947-51.
10Levy S,Maarek M,Coumel P,et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study[J]. Circulation, 1999,99 (23) : 3028-3035.
8Zhang Q,Lu X N,Sun N L.Effects of Verapamil and Metoprolol on heart rate variability in patients with coronary heart disease[J] .Journal of Peking University,2007,39(6):610-613.
9Wojtkowska I,Tysarowski A,Seliga K,et al.PPAR Gamma expression levels during development of heart failure in patients with coronary artery disease after coronary artery bypass-grafting[J] .PPAR Res,2014:242 790.
10Fox K,Ford I,Steg P G,et al.Ivabradine in stable coronary artery disease without clinical heart failure[J] .N Engl J Med,2014,371(12):1091-1099.
